hypothesis glutathione persister cells Drug-tolerant cancer are vulnerable to GPX4 inhibition Ferroptosis: Opportunities and Challenges in
Ferroptosis: Opportunities and Challenges in Cancer Role of Glutathione in Cancer: From Mechanisms to Therapies Low GPX4 drives a sustained drug tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation ScienceDirect Targeted therapy for drug tolerant persister cells after imatinib treatment for gastrointestinal stromal tumours British Journal of Cancer
Pay in 4 interest-free payments of $6.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17



